19090 Federal Register / Vol. 61, No. 84 / Tuesday, April 30, 1996 / Notices

actual damages under specified

circumstances. Pursuant to Section 6(b)

of the Act, the identities of the parties

are Southern Natural Gas Company,

Birmingham, AL; Tennessee Gas

Pipeline Company, its subsidiary and

affiliate companies, Houston, TX; and

Woodward Governor Company, Fort

Collins, CO; and its general areas of

planned activities are to document, from

a mechanical integrity perspective, the

impact of precision continuous engine

autobalancing on mechanical wear and

failure.

Membership in the program remains

open, and SwRI intends to file

additional written notifications

disclosing all changes in the

membership or planned activities.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–10574 Filed 4–29–96; 8:45 am]

BILLING CODE 4410–01–M

Drug Enforcement Administration

[DEA # 144W]

Controlled Substances: 1996

Aggregate Production Quotas

AGENCY: Drug Enforcement

Administration (DEA), Justice.

ACTION: Withdrawal of an interim notice

regarding levorphanol and

establishment of the revised 1996

aggregate production quota for heroin.

SUMMARY: DEA is withdrawing the

portion of the interim notice published

on March 18, 1996 (61 FR 11063) which

established the revised 1996 aggregate

production quota for levorphanol, and is

adopting without change the revised

1996 aggregate production quota for

heroin.

FOR FURTHER INFORMATION CONTACT:

Howard McClain, Jr., Chief, Drug and

Chemical Evaluation Section, Drug

Enforcement Administration,

Washington DC, 20537, (202) 307–7183.

SUPPLEMENTARY INFORMATION: Section

306 of the Controlled Substances Act

(21 U.S.C. 826), requires the Attorney

General to establish aggregate

production quotas for controlled

substances in Schedules I and II each

year. This responsibility has been

delegated to the Administrator of the

DEA pursuant to Section 0.100 of Title

28 of the Code of Federal Regulations.

The Administrator, in turn, has

redelegated this function to the Deputy

Administrator of the DEA pursuant to

Section 0.104 of Title 28 of the Code of

Federal Regulations.

On March 18, 1996, an interim notice

establishing revised 1996 aggregate

production quotas for heroin and

levorphanol was published in the

Federal Register (61 FR 11063). The

basis for the proposed increase in the

levorphanol aggregate production quota

was that there was only one bulk

manufacturer of levorphanol. A

comment was filed that pointed out that

there is more than one manufacturer of

levorphanol. Given that this was the

basis for the increase in the levorphanol

aggregate production quota, DEA is

withdrawing the revised 1996 aggregate

production quota for levorphanol.

No comments were received regarding

heroin, therefore, the revised 1996

aggregate production quota for heroin is

adopted without change.

The Office of Management and Budget

has determined that notices of aggregate

production quotas are not subject to

centralized review under Executive

Order 12866. This action has been

analyzed in accordance with the

principles and criteria contained in

Executive Order 12612, and it has been

determined that this matter does not

have sufficient federalism implications

to warrant the preparation of a

Federalism Assessment.

The Deputy Administrator hereby

certifies that this action will have no

significant impact upon small entities

whose interests must be considered

under the Regulatory Flexibility Act, 5

U.S.C. 601, et seq. The establishment of

annual aggregate production quotas for

Schedules I and II controlled substances

is mandated by law and by international

treaty obligations. While aggregate

production quotas are of primary

importance to large manufacturers, their

impact upon small entities is neither

negative nor beneficial. Accordingly, the

Deputy Administrator has determined

that this action does not require a

regulatory flexibility analysis.

Therefore, under the authority vested

in the Attorney General by Section 306

of the Controlled Substances Act of

1970 (21 U.S.C. 826), delegated to the

Administrator of the DEA by Section

0.100 of Title 28 of the Code of Federal

Regulations, and redelegated to the

Deputy Administrator, pursuant to

Section 0.104 of Title 28 of the Code of

Federal Regulations, the Deputy

Administrator hereby orders that the

revised 1996 aggregate production quota

for heroin be established at 5 grams,

expressed as anhydrous base.

Dated: April 24, 1996.

Stephen H. Greene,

Deputy Administrator.

[FR Doc. 96–10616 Filed 4–29–96; 8:45 am]

BILLING CODE 4410–09–M

NATIONAL CREDIT UNION

ADMINISTRATION

Sunshine Act Meeting

TIME AND DATE: 11:00 a.m., Friday, May

3, 1996.

PLACE: Board Room, 7th Floor, Room

7047, 1775 Duke Street, Alexandria, VA

22314–3428.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

1. Administrative Action under

Section 206 of the Federal Credit Union

Act. Closed pursuant to exemptions (8),

(9)(A)(ii), and (9)(B).

FOR FURTHER INFORMATION CONTACT:

Hattie Ulan, Acting Secretary of the

Board, Telephone (703) 518–6300.

Hattie Ulan,

Acting Secretary of the Board.

[FR Doc. 96–10703 Filed 4–25–96; 4:24 pm]

BILLING CODE 7535–01–M

NATIONAL FOUNDATION ON THE

ARTS AND THE HUMANITIES

Federal Council on the Arts and the

Humanities; Arts and Artifacts

Indemnity Panel Advisory Committee;

Notice of Meeting

Pursuant to the provisions of the

Federal Advisory Committee Act (Pub.

L. 92–463 as amended) notice is hereby

given that a meeting of the Arts and

Artifacts Indemnity Panel of the Federal

Council on the Arts and the Humanities

will be held at 1100 Pennsylvania

Avenue, N.W., Washington, D.C. 20506,

in Room 714, from 9:00 a.m. to 5:30

p.m., on Friday, May 17, 1996.

The purpose of the meeting is to

review applications for Certificates of

Indemnity submitted to the Federal

Council on the Arts and the Humanities

for exhibitions beginning after July 1,

1996.

Because the proposed meeting will

consider financial and commercial data

and because it is important to keep

values of objects, methods of

transportation and security measures

confidential, pursuant to the authority

granted me by the Chairman’s

Delegation of Authority to Close

Advisory Committee Meetings, dated

July 19, 1993, I have determined that the

meeting would fall within exemptions

(4) and (9) of 5 U.S.C. 552(b) and that

it is essential to close the meeting to

protect the free exchange of views and

to avoid interference with the

operations of the Committee.

It is suggested that those desiring

more specific information contact the